Conversations in Clinical Trial Readiness

Pandemic Impact on Clinical Trial Recruitment with Atul Mahableshwarkar, M.D., DFAPA

Are Virtual SIVs the Future?: Interview with Jennifer Brandl

Why every clinical trial needs to consider Middle East and African sites: Interview with Ahmed Hamouda

Increasing Access to People of African Descent in Pharma: Interview with Peju Oshisanya

How Can We Manage the Increasing Complexity of Clinical Trial Protocols? Interview with Ken Getz of Tufts Center for the Study of Drug Development

Struggling with the Silent Killer: An Honest Look at How Demanding Oncology Trials Have Become with Rebecca Setta

What Do You Do When You Don't Have Enough Trial Locations? with Krystyna Kowalczyk

Helping Sites and Teams Make the Shift to Decentralized Trials with Paul Evans

The Evolving Role of Sites in Decentralized & Virtual Trials with Mary Costello

Demystifying Decentralized Clinical Trials with R'Kes Starling

What We Learned from the Clin Ops Nightmares of 2020 with Kunal Sampat of Ceribell

Welcome to Conversations in Clinical Trial Readiness